Top compounds associated with response to EIF4H


Feature Type Standardized
Nominal ANOVA
mRNA erastin CTRPv2 pan-cancer AAC 0.0046 0.9
mRNA AM-580 CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.0043 0.9
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0045 0.9
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.0046 0.9
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.0051 0.9
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0036 0.9
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0052 0.9
mRNA GW843682X GDSC1000 pan-cancer AAC 0.0049 0.9
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.0031 0.9
Download CSV